Passage Bio, Inc. Common Stock (PASG) is a publicly traded Healthcare sector company. As of August 10, 2026, PASG trades at $4.47 with a market cap of $14.14M and a P/E ratio of -0.31. PASG moved +0.00% today. Year to date, PASG is -62.71%; over the trailing twelve months it is -21.58%. Its 52-week range spans $3.29 to $20.20. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces PASG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PASG insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $4.47 |
| Market Cap | $14.14M |
| P/E Ratio | -0.31 |
| EPS | $-14.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.20 |
| 52-Week Low | $3.29 |
| Volume | 4.80K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-45.52M |
| Gross Margin | 0.00% |
2 analysts cover PASG: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.